Role of Serum Brain-Derived Neurotrophic Factor as a Biomarker of Chronic Pain in Older Adults
Serum brain-derived neurotrophic factor (BDNF) has emerged as a promising biomarker for chronic pain (CP) research and treatment. Yet, most human studies have been limited by small sample sizes, inadequate control of confounders and a lack of focus on sex and mental health differences.
| Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2025 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/407822 |
| Online Access: | http://hdl.handle.net/10261/407822 https://api.elsevier.com/content/abstract/scopus_id/105002594963 |
| Access Level: | Open access |
| Keyword: | http://metadata.un.org/sdg/3 Ensure healthy lives and promote well-being for all at all ages |
| Summary: | Serum brain-derived neurotrophic factor (BDNF) has emerged as a promising biomarker for chronic pain (CP) research and treatment. Yet, most human studies have been limited by small sample sizes, inadequate control of confounders and a lack of focus on sex and mental health differences. |
|---|